Intellectus Partners, LLC Johnson & Johnson Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Intellectus Partners, LLC holds 9,315 shares of JNJ stock, worth $1.36 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

9,315

Previous 8,854 5.21%

Holding current value

$1.36 Million

Previous $1.29 Million 16.62%

% of portfolio

0.39%

Previous 0.36%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$145.48 - $167.38 $67,066 - $77,162	461 Added 5.21%	9,315 $1.51 Million
Q2 2024 Jul 18, 2024	BUY	$144.38 - $157.78 $129,220 - $141,213	895 Added 11.25%	8,854 $1.29 Million
Q1 2024 May 03, 2024	BUY	$155.22 - $162.74 $136,127 - $142,722	877 Added 12.38%	7,959 $1.26 Million
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $218,545 - $238,478	1,501 Added 26.89%	7,082 $1.11 Million
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $57,939 - $64,906	372 Added 7.14%	5,581 $869,000
Q2 2023 Jul 31, 2023	BUY	$154.35 - $166.11 $8,643 - $9,302	56 Added 1.09%	5,209 $862,000
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $1,963 - $2,343	13 Added 0.25%	5,153 $798,000
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $130,562 - $146,528	-815 Reduced 13.69%	5,140 $907,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $702,753 - $781,989	-4,356 Reduced 42.25%	5,955 $973,000
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $131,860 - $145,831	-784 Reduced 7.07%	10,311 $1.83 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $47,916 - $54,415	-303 Reduced 2.66%	11,095 $1.97 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $53,483 - $59,342	343 Added 3.1%	11,398 $1.95 Million
Q3 2021 Nov 16, 2021	BUY	$161.5 - $179.47 $631,303 - $701,548	3,909 Added 54.7%	11,055 $1.79 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $1,435 - $1,539	9 Added 0.13%	7,146 $1.18 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $36,124 - $40,233	-236 Reduced 3.2%	7,137 $1.17 Million
Q4 2020 Feb 18, 2021	BUY	$137.11 - $157.38 $951,406 - $1.09 Million	6,939 Added 1598.85%	7,373 $1.16 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $1 Million - $1.15 Million	-7,312 Reduced 94.4%	434 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $21,197 - $23,228	-151 Reduced 1.91%	7,746 $1.15 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $175,310 - $211,649	-1,361 Reduced 14.7%	7,897 $1.11 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $91,023 - $126,117	819 Added 9.7%	9,258 $1.21 Million
Q4 2019 Jan 24, 2020	SELL	$127.5 - $146.44 $151,342 - $173,824	-1,187 Reduced 12.33%	8,439 $1.23 Million
Q3 2019 Oct 11, 2019	BUY	$126.95 - $142.14 $227,621 - $254,857	1,793 Added 22.89%	9,626 $1.25 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $113,575 - $124,911	866 Added 12.43%	7,833 $1.09 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $20,115 - $22,366	-160 Reduced 2.24%	6,967 $974,000
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $244,451 - $294,201	-1,990 Reduced 21.83%	7,127 $920,000
Q3 2018 Nov 15, 2018	SELL	$121.58 - $142.88 $72,704 - $85,442	-598 Reduced 6.16%	9,117 $1.26 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $457,302 - $504,640	-3,830 Reduced 28.28%	9,715 $1.18 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $116,217 - $137,622	-929 Reduced 6.42%	13,545 $1.74 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $285,272 - $312,229	-2,174 Reduced 13.06%	14,474 $2.02 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $28,224 - $29,512	-218 Reduced 1.29%	16,648 $2.16 Million
Q2 2017 Aug 15, 2017	BUY	N/A	16,866	16,866 $2.23 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Johnson & Johnson Transaction History